199 related articles for article (PubMed ID: 23474819)
1. A patient-derived olfactory stem cell disease model for ataxia-telangiectasia.
Stewart R; Kozlov S; Matigian N; Wali G; Gatei M; Sutharsan R; Bellette B; Wraith-Kijas A; Cochrane J; Coulthard M; Perry C; Sinclair K; Mackay-Sim A; Lavin MF
Hum Mol Genet; 2013 Jun; 22(12):2495-509. PubMed ID: 23474819
[TBL] [Abstract][Full Text] [Related]
2. The appropriateness of the mouse model for ataxia-telangiectasia: neurological defects but no neurodegeneration.
Lavin MF
DNA Repair (Amst); 2013 Aug; 12(8):612-9. PubMed ID: 23731731
[TBL] [Abstract][Full Text] [Related]
3. A Patient-Specific Stem Cell Model to Investigate the Neurological Phenotype Observed in Ataxia-Telangiectasia.
Stewart R; Wali G; Perry C; Lavin MF; Féron F; Mackay-Sim A; Sutharsan R
Methods Mol Biol; 2017; 1599():391-400. PubMed ID: 28477134
[TBL] [Abstract][Full Text] [Related]
4. Ataxia-telangiectasia and cellular responses to DNA damage.
Meyn MS
Cancer Res; 1995 Dec; 55(24):5991-6001. PubMed ID: 8521380
[TBL] [Abstract][Full Text] [Related]
5. Ataxia telangiectasia mutated is essential during adult neurogenesis.
Allen DM; van Praag H; Ray J; Weaver Z; Winrow CJ; Carter TA; Braquet R; Harrington E; Ried T; Brown KD; Gage FH; Barlow C
Genes Dev; 2001 Mar; 15(5):554-66. PubMed ID: 11238376
[TBL] [Abstract][Full Text] [Related]
6. Ataxia-telangiectasia: is ATM a sensor of oxidative damage and stress?
Rotman G; Shiloh Y
Bioessays; 1997 Oct; 19(10):911-7. PubMed ID: 9363685
[TBL] [Abstract][Full Text] [Related]
7. [Mosaic forms of ataxia-telangiectasia].
Kuranova ML; Pleskach NM; Ledashcheva TA; Mikhel'son VM; Spivak IM
Tsitologiia; 2014; 56(8):619-29. PubMed ID: 25697008
[TBL] [Abstract][Full Text] [Related]
8. Presence of ATM protein and residual kinase activity correlates with the phenotype in ataxia-telangiectasia: a genotype-phenotype study.
Verhagen MM; Last JI; Hogervorst FB; Smeets DF; Roeleveld N; Verheijen F; Catsman-Berrevoets CE; Wulffraat NM; Cobben JM; Hiel J; Brunt ER; Peeters EA; Gómez Garcia EB; van der Knaap MS; Lincke CR; Laan LA; Tijssen MA; van Rijn MA; Majoor-Krakauer D; Visser M; van 't Veer LJ; Kleijer WJ; van de Warrenburg BP; Warris A; de Groot IJ; de Groot R; Broeks A; Preijers F; Kremer BH; Weemaes CM; Taylor MA; van Deuren M; Willemsen MA
Hum Mutat; 2012 Mar; 33(3):561-71. PubMed ID: 22213089
[TBL] [Abstract][Full Text] [Related]
9. The neurological phenotype of ataxia-telangiectasia: solving a persistent puzzle.
Biton S; Barzilai A; Shiloh Y
DNA Repair (Amst); 2008 Jul; 7(7):1028-38. PubMed ID: 18456574
[TBL] [Abstract][Full Text] [Related]
10. Current and potential therapeutic strategies for the treatment of ataxia-telangiectasia.
Lavin MF; Gueven N; Bottle S; Gatti RA
Br Med Bull; 2007; 81-82():129-47. PubMed ID: 17586848
[TBL] [Abstract][Full Text] [Related]
11. An anti-sense construct of full-length ATM cDNA imposes a radiosensitive phenotype on normal cells.
Zhang N; Chen P; Gatei M; Scott S; Khanna KK; Lavin MF
Oncogene; 1998 Aug; 17(7):811-8. PubMed ID: 9779997
[TBL] [Abstract][Full Text] [Related]
12. Role for ATM in DNA damage-induced phosphorylation of BRCA1.
Gatei M; Scott SP; Filippovitch I; Soronika N; Lavin MF; Weber B; Khanna KK
Cancer Res; 2000 Jun; 60(12):3299-304. PubMed ID: 10866324
[TBL] [Abstract][Full Text] [Related]
13. Ataxia telangiectasia syndrome: moonlighting ATM.
Zaki-Dizaji M; Akrami SM; Abolhassani H; Rezaei N; Aghamohammadi A
Expert Rev Clin Immunol; 2017 Dec; 13(12):1155-1172. PubMed ID: 29034753
[TBL] [Abstract][Full Text] [Related]
14. Novel ATM mutations with ataxia-telangiectasia.
Liu XL; Wang T; Huang XJ; Zhou HY; Luan XH; Shen JY; Chen SD; Cao L
Neurosci Lett; 2016 Jan; 611():112-5. PubMed ID: 26628246
[TBL] [Abstract][Full Text] [Related]
15. Loss of ATM impairs proliferation of neural stem cells through oxidative stress-mediated p38 MAPK signaling.
Kim J; Wong PK
Stem Cells; 2009 Aug; 27(8):1987-98. PubMed ID: 19544430
[TBL] [Abstract][Full Text] [Related]
16. ATM-deficient human neural stem cells as an in vitro model system to study neurodegeneration.
Carlessi L; Fusar Poli E; De Filippis L; Delia D
DNA Repair (Amst); 2013 Aug; 12(8):605-11. PubMed ID: 23707302
[TBL] [Abstract][Full Text] [Related]
17. The role of ATM in DNA damage responses and cancer.
Canman CE; Lim DS
Oncogene; 1998 Dec; 17(25):3301-8. PubMed ID: 9916992
[TBL] [Abstract][Full Text] [Related]
18. Ataxia-telangiectasia, an evolving phenotype.
Chun HH; Gatti RA
DNA Repair (Amst); 2004; 3(8-9):1187-96. PubMed ID: 15279807
[TBL] [Abstract][Full Text] [Related]
19. Robust reprogramming of Ataxia-Telangiectasia patient and carrier erythroid cells to induced pluripotent stem cells.
Bhatt N; Ghosh R; Roy S; Gao Y; Armanios M; Cheng L; Franco S
Stem Cell Res; 2016 Sep; 17(2):296-305. PubMed ID: 27596957
[TBL] [Abstract][Full Text] [Related]
20. Neurodegeneration in ataxia-telangiectasia: Multiple roles of ATM kinase in cellular homeostasis.
Choy KR; Watters DJ
Dev Dyn; 2018 Jan; 247(1):33-46. PubMed ID: 28543935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
